Abstract
Dogs with neoplasm are at risk of thrombosis, yet there is no information on the haemostatic alterations that may result from the surgeries performed to remove neoplastic masses. The aim of this study was to observe the characteristics of haemostasis in dogs undergoing surgery to remove a malignancy by means of rotational thromboelastometry and thrombin generation. Haemostasis was assessed immediately before surgery (T0), 24 h after surgery (T1), and two weeks after surgery (T2). Statistically significant differences were found between the thromboelastometric parameters at T0 vs. T1, with increases observed in MCF, the α angle, and G parameters in the ex-TEM and in-TEM profiles. In the thromboelastometric analysis performed after surgery differences were identified between T1 and T2, with a decrease observed in parameters such as CFT, MCF, the α angle, and G. Between T0 and T2, only a significant decrease in CT was detected in the fib-TEM profile. No differences were found in the comparison among the results obtained via thrombin generation. In dogs with resectable malignancies, the surgeries performed to remove cancer affected coagulation, causing a tendency towards hypercoagulability. The interference with coagulation was transient, and 2 weeks after surgery, the thromboelatometric results returned to those obtained before surgery (T0).
Subject
General Veterinary,Animal Science and Zoology
Reference38 articles.
1. Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 1-Defining populations at risk;DeLaforcade;J. Vet. Emerg. Crit. Care,2019
2. Use of Viscoelastography in Malignancy-Associated Coagulopathy and Thrombosis: A Review;Walsh;Semin. Thromb. Hemost.,2019
3. Persistence of hypercoagulable state after resection of intra-abdominal malignancies;Thorson;J. Am. Coll. Surg.,2013
4. Long-term coagulation changes after resection of thoracoabdominal malignancies;Valle;J. Am. Coll. Surg.,2014
5. Reddel, C.J., Tan, C.W., and Chen, V.M. (2019). Thrombin Generation and Cancer: Contributors and Consequences. Cancers, 11.